Article
Jake Angeli: The Psychedelic Guru Who Stormed The Capitol
Capitol insurrectionist Jake Angeli is a self-appointed psychedelic guru who has opined about the urgent need for psychedelic shamanism to heal the world’s biggest problems.
Articles
Every article, newest first.
All articles, page 4
Article
Psymposia 2020 Staff Book Picks
The Psymposia staff reflects on some of the books that kept us company throughout 2020, which we’d like to recommend to our readers for 2021. The list includes works of intersectional analysis, psychedelic history, surveillance capitalism, and more. We hope you appreciate these insights as much as w
Article
Livestream #2: Team trip reports and experiential typewriters
Weeoo weeoo livestream alert for Thursday, December 17th at 8PM ET!!. Last time we popped bottles and jammed in the comments – come hang out with us again for some reflections on 2020.
Article
Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform
Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”
Article
Thea Riofrancos on the Implications of Global Energy Transition and the Impacts of Lithium Extraction
Thea Riofrancos is a political scientist whose research has focused on political conflict related to extraction, energy, and infrastructure in a rapidly warming and politically unstable world. She also serves on the steering committee for Democratic Socialists of America for a Green New Deal.
Article
The Big & Dandy List of Psychedelic-Mining-Extractive-Industry Ties
This list is by no means exhaustive, but it spotlights a number of psychedelic pharmaceutical companies and executives with ties to extractive industry.
Article
Why are so many extractive industry executives speculating on psychedelics?
Extractive industry is highly speculative by nature and firms are risk tolerant—they either “strike gold” or they don’t. When their gambles fail, psychedelic startups can take over their corporate shells to quickly go public with minimal regulatory scrutiny.
Article
Will Extractive Industry Bring Its Disregard for Indigenous People Into The Psychedelic Industry?
A mining firm’s conflict with Argentinian communities illustrates extractive industry’s practices and values, and raises questions about how these corporate approaches will translate into the psychedelic pharmaceutical industry.
Article
As Psychedelics Enter the Mainstream, Mining Companies Look to Dig Up Profits
Canadian mining and exploration company AIS has had a number of executives move on to found psychedelic pharmaceutical businesses. Why? Because psychedelics are where the money’s at.
Article
An Open Letter and Call to Action for MAPS Canada
The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers,
Article
Psychedelic Media Should Stop Parroting Corporate Press Releases
When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.
Article
ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0”
Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies’ (MAPS) approach “MDMA 1.0.” MAPS’ executive director, Rick Doblin, says that if that’s the case, ATAI is “MDMA 0.5.”